Thai Truc Thanh, Nguyen Diep Bich, Nguyen Trang Thu, Hoang Hai-Van Thi, Li Michael, Li Li, Vu Tuong-Vi Thi, Tran Lan-Phuong Thi, Van Do Dung, Shoptaw Steve, Le Giang Minh
Faculty of Public Health, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.
Center for Training and Research on Substance Use & HIV, Hanoi Medical University, Ha Noi City, Vietnam.
Addiction. 2025 Jul;120(7):1450-1459. doi: 10.1111/add.70010. Epub 2025 Feb 6.
Identifying those who use methamphetamine or are at high risk of using methamphetamine is essential so that early, appropriate intervention can be made. This study evaluated the use of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) for identifying methamphetamine use among people on methadone maintenance treatment (MMT) in Vietnam.
From June 2021 to May 2023, all people on MMT at 15 methadone clinics in Hanoi and Ho Chi Minh City, Vietnam, were invited to participate in this study. Participants underwent a face-to-face interview to complete the 8-item ASSIST. Participants also had a urine drug test (UDT) for methamphetamine use. Discriminant properties of the ASSIST were evaluated using UDT as the reference.
Among 6709 participants, 10.7% (n = 717) tested positive for methamphetamine use via UDT. The ASSIST demonstrated robust discriminant abilities to identify those who used methamphetamine [area under the curve (AUC) = 0.872; 95% confidence interval (CI) = 0.856-0.887]. At the commonly used cutoff of 4, the ASSIST had a sensitivity of 83.8% and a specificity of 82.0%. At this cutoff, 82.2% of the ASSIST results aligned with UDT outcomes (kappa coefficient = 0.41, P < 0.001) and the ASSIST identified a prevalence of 25.0%. At higher cutoffs, the sensitivity of the ASSIST decreased but both the specificity and the agreement with the UDT results increased.
The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) appears to be reliable and valid in identifying methamphetamine use among people on methadone treatment in Vietnam. Cutoff adjustments may help to reduce false positive rates.
识别使用甲基苯丙胺或有高风险使用甲基苯丙胺的人群至关重要,以便能够进行早期、适当的干预。本研究评估了酒精、吸烟和物质使用筛查测试(ASSIST)在越南美沙酮维持治疗(MMT)人群中识别甲基苯丙胺使用情况的效用。
2021年6月至2023年5月,越南河内和胡志明市15家美沙酮诊所的所有接受美沙酮维持治疗的患者受邀参与本研究。参与者接受面对面访谈以完成8项ASSIST测试。参与者还进行了甲基苯丙胺使用的尿液药物检测(UDT)。以UDT为参照评估ASSIST的判别特性。
在6709名参与者中,10.7%(n = 717)的尿液药物检测显示甲基苯丙胺使用呈阳性。ASSIST在识别使用甲基苯丙胺的人群方面表现出强大的判别能力[曲线下面积(AUC)= 0.872;95%置信区间(CI)= 0.856 - 0.887]。在常用的截断值为4时,ASSIST的灵敏度为83.8%,特异度为82.0%。在此截断值下,82.2%的ASSIST结果与尿液药物检测结果一致(kappa系数 = 0.41,P < 0.001),ASSIST识别出的患病率为25.0%。在更高的截断值下,ASSIST的灵敏度下降,但特异度以及与尿液药物检测结果的一致性均增加。
酒精、吸烟和物质使用筛查测试(ASSIST)在识别越南接受美沙酮治疗人群中的甲基苯丙胺使用情况方面似乎可靠且有效。调整截断值可能有助于降低假阳性率。